Full-Time

Senior Principal Scientist

Veterinary Pathology, Board Certification

Confirmed live in the last 24 hours

MSD

MSD

Senior

H1B Sponsorship Available

North Wales, PA, USA

Hybrid work environment with in-office presence required.

Category
Veterinary Professionals
Medical, Clinical & Veterinary
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • Doctor of Veterinary Medicine (DVM)
  • Residency in anatomic / toxicologic pathology
  • ACVP or ECVP-board certification in anatomic pathology
  • Over 5 years of experience as a pathologist in biotech, pharma or at a CRO
Responsibilities
  • Employ both routine H&E evaluations as well as other specialized techniques to characterize the safety profile of new drugs from toxicology and investigative studies
  • Work independently to analyze data, interpret and determine the significance of results for postmortem evaluations, review literature and design experiments to help teams solve scientific problems
  • Serve as Program Pathologist, providing scientific input and oversight across studies from very early discovery to late-stage development, following molecules throughout their lifetime
  • Communicate with study team/drug development teams on study findings and participate on cross-functional teams to elucidate mechanisms of toxicity and may be required to provide advanced scientific and/or technical guidance to technical and/or Ph.D/D.V.M. level staff. Utilizing additional tools and applications that are all available on-site, including: An industry-leading suite of on-site in vitro and in vivo assay capabilities, Access to robust historical controls slide archive and data base, Transmission electron microscopy, Immunohistochemistry and in situ hybridization, Quantitative digital image analysis and targeted machine learning applications, In vivo imaging tools (e.g., magnetic resonance imaging)
  • Develop novel biomarkers and predictive models to de-risk drug candidates for safety-related liabilities
  • Our Company's pathologists also serve as nonclinical safety assessment leads on drug development teams, overseeing the design and execution of studies, and generation of regulatory strategy and communications with global regulatory agencies to support the development of drug candidates
  • Our Company's pathologists work in a hybrid work environment and routinely interact with each other, share slides and opinions/experiences, and help each other learn and grow

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A